Brief: FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165

Kyntra Bio

03/06/2024 21:06

June 3 (Reuters) - FibroGen Inc  FGEN.O :
    * FIBROGEN ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW
DRUG
APPLICATION FOR FG-3165, A GALECTIN-9 TARGETING MONOCLONAL
ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH SOLID TUMORS
    * FIBROGEN INC - PLAN TO BEGIN ENROLLMENT IN 2H 2024
    * FIBROGEN INC - SAFETY AND EFFICACY OF FG-3165 WILL BE
EVALUATED
IN A PHASE 1 TRIAL IN SELECT SOLID TUMORS

Source text for Eikon:  ID:nGNX5wXXCG 
Further company coverage:  FGEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))